<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5431">
  <stage>Registered</stage>
  <submitdate>13/09/2005</submitdate>
  <approvaldate>13/09/2005</approvaldate>
  <nctid>NCT00208390</nctid>
  <trial_identification>
    <studytitle>A Multi-centre Study to Assess the Long-term Performance of the Summit Hip in Primary Total Hip Replacement</studytitle>
    <scientifictitle>Prospective, Uncontrolled, Multi-Centre, Post-Marketing Surveillance Study to Evaluate the Long-Term Performance of Summit Tapered Hip in Cementless Total Hip Arthroplasty</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>CT01/25</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Rheumatoid Arthritis</healthcondition>
    <healthcondition>Osteoarthritis</healthcondition>
    <healthcondition>Post-traumatic Arthritis</healthcondition>
    <healthcondition>Collagen Disorders</healthcondition>
    <healthcondition>Avascular Necrosis</healthcondition>
    <healthcondition>Traumatic Femoral Fractures</healthcondition>
    <healthcondition>Nonunion of Femoral Fractures</healthcondition>
    <healthcondition>Congenital Hip Dysplasia</healthcondition>
    <healthcondition>Slipped Capital Femoral Epiphysis</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Rheumatoid arthritis</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Injuries and Accidents</conditioncode1>
      <conditioncode2>Fractures</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Research that is not of generic health relevance and not applicable to specific health categories listed above</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Skin</conditioncode1>
      <conditioncode2>Other skin conditions</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Summit Tapered Hip System

Other: Summit Tapered Hip System - A cementless, tapered femoral component for use in total hip replacement


Treatment: devices: Summit Tapered Hip System
A cementless, tapered femoral component for use in total hip replacement

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Kaplan-Meier survivorship calculated at the five-year time point</outcome>
      <timepoint>5yrs post-surgery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Kaplan-Meier survivorship calculations</outcome>
      <timepoint>Annually</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Harris Hip score</outcome>
      <timepoint>6mths, 1yr, 2yrs, 3yrs, 5yrs, 7yrs, 10yrs and 15yrs post-surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Oxford score</outcome>
      <timepoint>6mths and Annually post-surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>UCLA activity rating</outcome>
      <timepoint>6mths and Annually post-surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Thigh pain analysis</outcome>
      <timepoint>6mths and Annually post-surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Radiological analysis</outcome>
      <timepoint>pre-discharge, 6mths, 1yr, 2yrs, 3yrs, 5yrs, 7yrs, 10yrs and 15yrs post-surgery</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>i) Male or female subjects, aged between 18 and 70 years (inclusive).

        ii) Subjects who are able to give voluntary, written informed consent to participate in
        this investigation and from whom consent has been obtained.

        iii) Subjects who, in the opinion of the Investigator, are able to understand this
        investigation, co-operate with the investigational procedures and are willing to return to
        the hospital for all the required post-operative follow-ups.

        iv) Subjects who require primary total hip replacement and are considered suitable for a
        cementless femoral stem.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>i) Subjects who, in the opinion of the Investigator, have an existing condition that would
        compromise their participation and follow-up in this study.

        ii) Subjects who have previously undergone a hemi-arthroplasty or total hip arthroplasty.

        iii) Women who are pregnant.

        iv) Subjects who are known drug or alcohol abusers or with psychological disorders that
        could effect follow-up care or treatment outcomes.

        v) Subjects who have participated in a clinical study with an investigational product in
        the last 12 months.

        vi) Subjects who are currently involved in any injury litigation claims.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/02/2003</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>275</actualsamplesize>
    <recruitmentstatus>Terminated</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/05/2012</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>China</country>
      <state>Shanghai</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hong Kong</country>
      <state>Pokfulam</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Bergamo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Korea, Republic of</country>
      <state>Seoul</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>DePuy International</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to monitor the performance of the Summit hip in the treatment
      of patients with hip joint disease requiring a total hip replacement. Patients who enter the
      study will be evaluated at regular intervals following hip surgery using patient, clinical
      and x-ray assessments.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00208390</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>